Epiduo and Wellbutrin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Epiduo (adapalene; benzoyl peroxide) and Wellbutrin (bupropion hydrochloride). Common drug interactions include drug effect decreased among females and optic neuropathy among males.

The phase IV clinical study analyzes what interactions people have when they take Epiduo and Wellbutrin. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Epiduo?

Epiduo has active ingredients of adapalene; benzoyl peroxide. It is often used in acne. eHealthMe is studying from 1,581 Epiduo users. Check the latest studies of Epiduo.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,110 Wellbutrin users. Check the latest studies of Wellbutrin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 18, 2026

26 people who take Epiduo and Wellbutrin together, and have interactions are studied.

Epiduo and Wellbutrin drug interactions.

What are the common drug interactions of Epiduo and Wellbutrin, by gender? *:

female:

  1. Drug effect decreased
  2. Dry skin
  3. Ear pain
  4. Erythema (redness of the skin)
  5. Headache (pain in head)
  6. Histoplasmosis (infection caused by breathing in spores of a fungus)
  7. Hypoacusis (loss of hearing)
  8. Muscle spasms (muscle contraction)
  9. Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
  10. Pruritus (severe itching of the skin)

male:

  1. Optic neuropathy (optic nerve damage)
  2. Therapeutic response unexpected
  3. Muscle spasms (muscle contraction)
  4. Weight decreased
  5. Retinal degeneration (death of the cells of the retina)
  6. Retinal tear
  7. Suicidal ideation
  8. Surgery
  9. Constipation
  10. Drug ineffective

What are the common drug interactions of Epiduo and Wellbutrin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Optic neuropathy (optic nerve damage)
  2. Retinal degeneration (death of the cells of the retina)
  3. Retinal tear
  4. Therapeutic response unexpected
  5. Visual impairment

20-29:

  1. Constipation
  2. Drug ineffective
  3. Dry eye (lack of adequate tears)
  4. Optic neuropathy (optic nerve damage)
  5. Therapeutic response unexpected
  6. Eructation (release of gas from the digestive tract)
  7. Flatulence (flatus expelled through the anus)
  8. Muscle spasms (muscle contraction)
  9. Glaucoma (increased fluid pressure in the eye with vision loss)
  10. Suicidal ideation

30-39:

  1. Periorbital disorder (gum inflammation to serious disease that results in major damage to the soft tissue and bone that support the teeth)
  2. Eye swelling
  3. Headache (pain in head)

40-49:

n/a

50-59:

  1. Drug effect decreased
  2. Dry skin
  3. Erythema (redness of the skin)
  4. Pruritus (severe itching of the skin)
  5. Rash
  6. Seborrhoea (a disease of the sebaceous glands characterized by excessive secretion of sebum)
  7. Skin burning sensation
  8. Skin irritation

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 21 people, 80.77%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 50.00%
  3. Gilles De La Tourette Syndrome (a condition that causes people to make repeated, quick movements or sounds that they cannot control): 10 people, 38.46%
  4. Muscle Twitching: 9 people, 34.62%
  5. Dry Eyes (lack of adequate tears): 3 people, 11.54%
  6. Drowsiness: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Epiduo and Wellbutrin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Epiduo and Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Epiduo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epiduo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Wellbutrin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on adapalene; benzoyl peroxide and bupropion hydrochloride (the active ingredients of Epiduo and Wellbutrin, respectively), and Epiduo and Wellbutrin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: